Acurx Pharmaceuticals LLC
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -4,121 | -4,377 | -5,114 | -3,114 |
EBIT | -8,243 | -8,755 | -10,229 | -6,229 |
Net Income | -4,121 | -4,377 | -5,114 | -3,114 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -2,880 | -3,062 | -4,197 | -2,093 |
Cash | 6,360 | 8,920 | 7,474 | 7,052 |
Basic Shares | 15,824 | 15,472 | 13,461 | 13,005 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -14,577 | -12,092 | -12,814 | -4,600 |
EBIT | -29,155 | -24,185 | -12,880 | -4,600 |
Net Income | -14,577 | -12,091 | -12,681 | -4,600 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -9,800 | -7,542 | -5,013 | -3,351 |
Cash | 7,474 | 9,111 | 12,958 | 3,175 |
Basic Shares | 12,671 | 10,816 | 10,215 | 9,916 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.26 |
2024-03-31 | -$0.28 |
2023-12-31 | -$0.37 |
2023-09-30 | -$0.24 |
